Coapt Systems, makers of the Endotine device which I use for browlifts, has recently announced FDA approval for their hyaluronic acid filler Hydrelle. What makes Hydrelle significant is that it is one of the first FDA-approved hyaluronic acid fillers that contains lidocaine, an anesthetic. Therefore, Hydrelle may be less painful to inject.
According to the company’s press release:
Hydrelle represents an attractive value for patients seeking a safe and cost-effective filler option, since patients only require approximately 50% of typical injection volumes, thus requiring fewer syringes to fully correct facial wrinkles. Hydrelle also represents a significant opportunity for aesthetic professionals to expand their respective practices by offering patients an advanced, long-lasting dermal filler with an affordable price, particularly during volatile economic times.
It seems there is a new hyaluronic acid filler on the market every month. Currently in my practice we utilize Restylane, Perlane, Juvederm Ultra, Juvederm Ultra Plus, and Prevelle Silk. In the past I’ve also used Hylaform and Hylaform Plus. In my opinion, adding lidocaine to the injection isn’t that big a deal. Prevelle Silk has lidocaine in it as well.
Overall, I’ve been very happy with the selection of fillers I utilize. My only complaint is the price. If a company can make a long-lasting (one year or so) filler at half the cost of current fillers then they’d have a huge fan in myself. I’m not a proponent of permanent fillers.
Thanks for reading.
Michigan-based Plastic Surgeon
Anthony Youn, M.D.:
